Concurrent chemoradiotherapy for T3–4 and N0–1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia

The aim of this study was to evaluate the toxicity and efficacy of radiotherapy concurrent with weekly cisplatin for T3–4 and N0–1 nasopharyngeal cancer. Between 2005 and 2010, 70 patients with nasopharyngeal cancer (T3–4 N0–1 M0, World Health Organization Type 2–3) from Vietnam, Indonesia, Malaysia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohno, Tatsuya, Wakatsuki, Masaru, Thinh, Dang Huy Quoc, Tung, Ngo Thanh, Erawati, Dyah, Supriana, Nana, Beena Devi, C.R., Kato, Shingo, Thephamongkhol, Kullathorn, Chansilpa, Yaowalak, Calaguas, Miriam Joy C., Xiaoting, Xu, Jianping, Cao, Banu, Parvin Akhter, Cho, Chul-Koo, Karasawa, Kumiko, Nakano, Takashi, Tsujii, Hirohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708910/
https://www.ncbi.nlm.nih.gov/pubmed/26254458
http://dx.doi.org/10.1093/jrr/rrv046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708910/
https://www.ncbi.nlm.nih.gov/pubmed/26254458
http://dx.doi.org/10.1093/jrr/rrv046

Ejemplares similares